Search clinical trials for: Enzalutamide tablet
Total 7570 results
-
Tasly Pharmaceutical Group Co., LtdCompleted
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedProstate Cancer | Pharmacokinetics of EnzalutamideUnited States
-
Yiling Pharmaceutical Inc.Completed
-
The National Institutes of Pharmaceutical R&D Co...CompletedIdiopathic Pulmonary FibrosisUnited States
-
Sunshine Lake Pharma Co., Ltd.CompletedNonalcoholic Steatohepatitis (NASH)China
-
ESSA PharmaceuticalsRecruitingProstate CancerCanada, United States, Australia
-
Atridia Pty Ltd.CompletedInflammatory Bowel DiseaseAustralia
-
Lexicon PharmaceuticalsCompletedIrritable Bowel SyndromeUnited States
-
Harmony Biosciences, LLCActive, not recruitingPrader-Willi SyndromeUnited States
-
Paratek Pharmaceuticals IncActive, not recruitingMycobacterium Infections, Nontuberculous | Nontuberculous Mycobacterial Lung Disease | Mycobacterium Abscessus Infection | Nontuberculous Mycobacterial Pulmonary InfectionUnited States
-
Groupe Hospitalier Pitie-SalpetriereCompletedEpilepsy | Prostate Cancer | Neuropathy | EncephalopathyFrance
-
Dong Wha Pharmaceutical Co. Ltd.CompletedDiabetic Kidney DiseaseKorea, Republic of
-
Rigshospitalet, DenmarkCompletedHyponatremia | Metabolic Bone DiseaseDenmark
-
Radboud University Medical CenterActive, not recruitingProstatic Neoplasms, Castration-ResistantNetherlands
-
Fundación Canaria de Investigación SanitariaHospital Universitario de CanariasUnknown
-
Sinew Pharma Inc.Completed
-
Translational Research Center for Medical Innovation...Kagawa UniversityCompleted
-
Aveiro UniversityCompletedSpeech DisordersPortugal
-
Andreas JosefssonGöteborg University; Umeå University; Sahlgrenska University Hospital, Sweden; Sundsvall... and other collaboratorsTerminated
-
Hinova Pharmaceuticals Inc.CompletedMetastatic Castration Resistant Prostate CancerChina
-
Macquarie University, AustraliaUnknown
-
National Cancer Institute (NCI)Terminated
-
Hinova Pharmaceuticals USA, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Prostate Cancer MetastaticGermany, Spain, Denmark, France, United Kingdom, Russian Federation, Poland, Australia, Italy, Netherlands, United States, Finland, Canada, Austria
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedProstate Cancer | Castration Resistant Prostate CancerUnited States
-
Astellas Pharma IncPfizerCompletedCastration-resistant Prostate CancerJapan
-
Case Comprehensive Cancer CenterCompletedAdenocarcinoma of the ProstateUnited States
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedKidney Diseases | Healthy Subjects | Pharmacokinetics of MDV3100Moldova, Republic of
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedHealthy Subjects | Relative Bioavailability | Castration Resistant Prostate Cancer (CRPC) | MDV3100Germany
-
Fulcrum TherapeuticsCompletedHealthy Adult SubjectsUnited States
-
European Organisation for Research and Treatment...Bayer; Latin American Cooperative Oncology Group; UNICANCER; Astellas Pharma Europe... and other collaboratorsActive, not recruitingProstate CancerSpain, Belgium, France, Italy, United Kingdom, Denmark, Canada, Ireland, Brazil, Norway, Poland, Switzerland
-
Ricardo Pereira MestreOncology Institute of Southern Switzerland; Institute of Oncology Research; Institute...TerminatedCOVID-19 InfectionSwitzerland
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Completed
-
Astellas Pharma Europe Ltd.Medivation, Inc.CompletedMetastatic Castration Resistant Prostate CancerCzechia, Netherlands, Denmark, Italy, Austria, Belgium, Bulgaria, France, Germany, Greece, Hungary, Ireland, Portugal, Slovenia, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.Medivation, Inc.WithdrawnMetastatic Castration-Resistant Prostate Cancer
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Alessa Therapeutics Inc.National Cancer Institute (NCI)Not yet recruitingProstate AdenocarcinomaUnited States
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom
-
Grupo Español de Tumores Huérfanos e InfrecuentesAstellas Pharma Inc; Apices Soluciones S.L.Completed
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownMetastatic Castrate-resistant Prostate (CRPC) CancerFrance
-
Weill Medical College of Cornell UniversitySagimet Biosciences Inc.RecruitingProstatic Neoplasms, Castration-ResistantUnited States
-
OHSU Knight Cancer InstituteAstellas Pharma US, Inc.; Oregon Health and Science UniversityActive, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Soft Tissues | Recurrent Prostate Carcinoma | Metastatic Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma AJCC v7 | Stage IV Prostate Adenocarcinoma AJCC v7United States
-
BayerTerminatedProstatic Cancer, Castration-ResistantUnited States
-
Astellas Pharma Global Development, Inc.PfizerCompletedAdvanced Hepatocellular CarcinomaCanada, United States, Hong Kong, Italy, Korea, Republic of, Puerto Rico, Spain, Taiwan, United Kingdom
-
AstraZenecaParexelCompleted
-
Zenith EpigeneticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedHealthy Subjects | Pharmacokinetics of MDV3100Netherlands
-
Valenta Pharm JSCRecruiting
-
Syntrix Biosystems, Inc.National Cancer Institute (NCI)Not yet recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Zenith EpigeneticsEnrolling by invitation